Quality of life and cognitive function in patients with pituitary insufficiency

Psychotherapy and Psychosomatics

Volumn 67, Issue 3, 1998, Pages 154-167

  Burman, Pia ^a   Deijen, Jan Berend ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Cognitive function; Corticosteroids; Growth hormone; Pituitary insufficiency; Pituitary tumours; Quality of life; Radiotherapy; Sex steroids; Thyroxine

Indexed keywords

CORTICOSTEROID; GROWTH HORMONE; SEX HORMONE; THYROXINE;

BEHAVIOR; COGNITION; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; MOOD; QUALITY OF LIFE; REVIEW; SOCIAL PSYCHOLOGY;

ADULT; AFFECT; CHILD; COGNITION; GROWTH HORMONE; HUMANS; HYPOPITUITARISM; QUALITY OF LIFE;

EID: 0031841264     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012276     Document Type: Review

References (94)

1. Dean HJ, McTaggart TL, Kish DG, Friesen HG: The educational, vocational and marital status of growth hormone deficient adults treated with growth hormone during childhood. Am Dis Child 1985;139:1105-1110.
2. Björk S, Jönsson B, Westphal O, Levin J-E: Quality of life in adults with growth-hormone deficiency: A controlled study. Acta Paediatr Scand 1989;356(suppl):55-59.
3. Takano K, Tanaka T, Saito T, and the Committee for the Study Group of Adult GH Deficiency: Psychosocial adjustment in a large cohort of adults with growth hormone deficiency treated with growth hormone in childhood: Summary of a questionnaire survey. Acta Paediatr Scand 1994;399(suppl):16-19.
4. Rikken B, van Bussbacht J, le Cessie S, Manten W, Spermon T, Grobbee R, Wit J-M, and the Dutch Growth Hormone Working Group: Impaired social status of growth hormone deficient adults as compared to controls with short or normal stature. Clin Endocrinol 1995;43:205-211.
5. McGauley GA: Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand 1989;356(suppl):70-72.
6. Rosén T, Wirén L, Wilhelmsen L, Wiklund I, Bengtsson B-Å: Decreased psychological wellbeing in adult patients with growth hormone deficiency. Clin Endocrinol 1994;40:111-116.
7. Burman P, Broman JE, Wiklund I, Erfurth EM, Hägg E, Karlsson FA: Quality of life in adults with growth hormone (GH) deficiency: Response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 1995;80:3585-3590.
8. Deijen JB, de Boer H, Blok GJ, van der Veen EA: Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 1996;21:313-322.
9. McEwen J: The Nottingham Health Profile; in Walker SR, Rosser RM (eds): Quality of Life, Assessment and Application. Lancaster, MTP Press, 1987, pp 95-111.
10. Dupuy HJ: The Psychological General Well-Being (PGWB) Index; in Wenger NK, Mattson ME, Furberg CF, Elinson J (eds): Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York, Le Jacq, 1984, pp 170-183.
11. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L: The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory. Behav Sci 1974;19:1-15.
12. Shacham S: A shortened version of the Profile of Mood States. J Pers Assess 1983;47:305-306.
13. Ploeg HM van der, Defares PB, Spielberger CD: Handledning bij de Zelf-Beoordelings vragenliijst ZBV. Een nederlandstalige bewerking van de Spielberger State-Trait Anxiety Inventory. Swets and Zeitlinger, Lisse, 1980.
14. Spielberger CD: Test manual of the State-Trait Anxiety Inventory - STAI Form Y. Palo Alto, Consulting Psychologists Press, 1980.
15. Lynch S, Merson S, Beshyah SA, Skinner E, Sharp P, Priest RG, Johnston DG: Psychiatric morbidity in adults with hypopituitarism. J R Soc Med 1994;87:445-447.
16. Degerblad M, Almkvist O, Grunditz R, Hall K, Kaiser L, Knutsson E, Ringertz H, Thorén M: Physical and physiological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol (Copenh) 1990;123: 185-193.
17. Whitehead HM, Boreham C, Mcllrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR: Growth hormone treatment of adults with growth hormone deficiency: Results of a 13-month placebo controlled cross-over study. Clin Endocrinol 1992;36:45-52.
18. Skuse D, Gilmour J, Tian CS, Hindmarsh P: Psychosocial assessment of children with short stature: A preliminary report. Acta Paediatr Suppl 1994;406:11-17.
19. Voss LD, Baily BJR, Mulligan J, Wilkin TJ, Betts PR: Short stature and school performance - The Wessex growth study. Acta Paediatr Scand 1991;377(suppl):29-31.
20. Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D: Quality of life measures in health care. II: Design, analysis, and interpretation. Br Med J 1992;305:1145-1148.
21. Holmes CS, Thompson RG, Hayford JT: Factors related to grade retention in children with short stature. Child Care Health Dev 1984;10: 199-210.
22. Stabler B, Clopper RR, Siegel PT, Stoppani C, Compton PG, Underwood LE: Academic achievement and psychological adjustment in short children. J Dev Behav Pediatr 1994;15: 1-6.
23. Steinhausen HC, Stahnke N: Negative impact of growth-hormone deficiency on psychological functioning in dwarfed children and adolescents. Eur J Pediatr 1977;126:263-270.
24. Abbot D, Rotnem D, Genel M, Cohen DJ: Cognitive and emotional functioning in hypopituitary short statured children. Schizophr Bull 1982;8:310-319.
25. Hunt SM, McKenna SP, Doward LC: Preliminary report on the development of a disease-specific instrument for assessing quality of life of adults with growth hormone deficiency. Acta Endocrinol 1993;128(suppl 2):37-40.
26. McGauley GA, Cuneo RC, Salomon F, Sönksen PH: Growth hormone deficiency and quality of life. Horm Res 1996;45(1-2):34-37.
27. Rosén T, Johansson G, Bengtsson B-Å: Consequences of growth hormone deficiency in adults, and effects of growth hormone replacement therapy. Acta Paediatr Suppl 1994;399:21-24.
28. Galatzer A, Wasserman N, Neuhaus H, Laron Z: Psychological well-being of young adults with growth deficiency before and after hGH treatment; in Laron Z, Butenandt O (eds): Growth Hormone Replacement Therapy in Adults: Pros and Cons. London, Freund, 1993, pp 115-122.
29. Page R, Hammersley MS, Burke CW, Wass JAH: An account of quality of life of patients after treatment for non-functioning pituitary tumours. Clin Endocrinol 1997;46:401-406.
30. Peace KA, Orme SM, Sebastian JP, Thompson AR, Barnes S, Ellis A, Belchetz PE: The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease. Clin Endocrinol 1997;46:445-450.
31. Godfrey HPD, Partridge FM, Knight RG: Course of insight disorder and emotional dysfunction following closed head injury: A controlled cross-sectional follow-up study. J Clin Exp Neuropsychol 1993;15:503-515.
32. Cousens P, Waters B, Said J, Stevens M: Cognitive effects of cranial irradiation in leukemia. A survey and metanalysis. J Child Psychol Psychiatry 1988;29:839-852.
33. Butler RW, Copeland DR: Neuropsychological effects of central nervous system prophylactic treatment in childhood leukemia: Methodological considerations. J Pediatr Psychol 1993;18: 319-338.
34. Garcia-Pérez A, Sierrasesumaga L, Narbona-Garcia J, Calvo-Manuel F, Aguirre-Ventallo M: Neuropsychological evaluation of children with intracranial tumors: Impact of treatment modalities. Med Pediatr Oncol 1994;23:116-123.
35. Smibert E, Anderson V, Godber T, Ekert H: Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia. Br J Cancer 1996;73: 825-830.
36. Crossen JR, Garwood D, Glatstein E, Neuwelt EA: Neurobehavioral sequelae of cranial irradiation in adults: A review of radiation-induced encephalopathy. J Clin Oncol 1994;12:627-642.
37. Hochberg FH, Slotnick B: Neuropsychologic impairment in astrocytoma survivors. Neurology 1980;30:172-177.
38. Lee PWH, Hung BKM, Woo EKW, Tai PTH, Choi DT: Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. J Neurol Neurosurg Psychiatry 1989;52:488-492.
39. Vigliani MC, Sichez N, Poisson M, Delattre JY: A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults. Int J Radiat Oncol Biol Phys 1996;35:527-533.
40. Grattan-Smith PJ, Morris JGL, Shores EA, Batchelor J, Sparks RS: Neuropsychological abnormalities in patients with pituitary tumours. Acta Neurol Scand 1992;86:626-631.
41. Mechanick JI, Hochberg FH, LaRocque A: Hypothalamic dysfunction following whole-brain irradiation. J Neurosurg 1986;65:490-494.
42. Abayomi OK: Pathogenesis of irradiation-induced cognitive dysfunction. Acta Oncol 1996; 35:659-663.
43. Lamproglou I, Chen QM, Boisserie G, Mazeron JJ, Poisson M, Baillet F, Le Poncin M, Delattre JY: Radiation-induced cognitive dysfunction: An experimental model in the old rat. Int J Radiat Oncol Biol Phys 1995;31:65-70.
44. Brambilla F: Psychopathological aspects of neuroendocrine disease: Possible parallels with the psychoendocrine aspects of normal aging. Psychoneuroendocrinology 1992;17:283-291.
45. Buchanan C, Eccles JS, Becker JB: Are adolescents the victims of raging hormones: Evidence for activational effects of hormones on moods and behavior at adolescence. Psychol Bull 1992; 111:62-107.
46. Donovan BT: Humours, Hormones and the Mind. An Approach to the Understanding of Behavior. Hampshire/London, Macmillan, 1988.
47. Stacpoole PW, Interlandi JW, Nicholson WE, Rabin D: Isolated ACTH deficiency: A heterogeneous disorder, clinical review and report of four new cases. Medicine 1982;61:13-24.
48. Sauter NP, Mclaughlin CD, Dyess EM, Kritzman J, Lechan RM: Isolated adrenocorticotropin deficiency associated with an antibody to a corticotroph antigen that is not adrenocorticotropin or other proopiomelanocortin-derived peptides. J Clin Endocrinol Metab 1990;70: 1391-1397.
49. Gonzalez-Clemente JM, Halperin I, Navarro MP, Conget JI, Martinez-Osaba MJ, Vilardell E: Déficit aislado de ACTH. Med Clin 1994; 102:220-224.
50. Kawai K, Tamai H, Nishikata H, Kobayashi N, Matsubayashi S: Severe depression associated with ACTH, PRL, and GH deficiency: A case report. Endocr J 1994;41:275-279.
51. Wolkowitz OM, Tinklenberg JR, Weingartner H: A psychopharmaco-logical perspective of cognitive functions. II. Specific pharmacologic agents. Neuropsychobiology 1985;14:133-156.
52. Veith JL, Sandman CA, George JM, Kendall JW: The relationship of endogenous ACTH levels to visual attentional functioning in patients with congenital adrenal hyperplasia. Psychoneuroendocrinology 1985;10:33-48.
53. Hoyenga K, Hoyenga KT: Gender-related differences. Origins and Outcomes. Needham Heights, Allyn & Bacon, 1993.
54. Baucom DH, Besch PK, Callahan S: Relations between testosterone concentration, sex role identity, and personality among females. J Pers Soc Psychol 1985;48:1218-1226.
55. Daitzman R, Zuckerman M: Disinhibitory sensation seeking, personality and gonadal hormones. Pers Individ Diff 1980;1:103-110.
56. Rubin RT, Reinisch JM, Hasker RF: Postnatal gonadal steroid effects on human behavior. Science 1981;211:1318-1324.
57. Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, Steiner B, Hull L, Callegari C, Swerdloff RS: Testosterone replacement therapy improves mood in hypogonadal men - a clinical research center study. J Clin Endocrinol Metab 1996;81:3578-3583.
58. Fink G, Sumner BE, Rosie R, Grace O, Quinn JP: Estrogen control of central monoamission: Effect on mood, mental state and memory. Cell Mol Neurobiol 1996;16:325-344.
59. Finkelstein JW, Susman EJ, Chinchilli VM, Kunselman SJ, Dárcangelo MR, Schwab J, Demers LM, Liben LS, Lookingbill G, Kulin HE: Estrogen and testosterone increases self-reported aggressive behaviour in hypogonadal adolescents. J Clin Endocrinol Metab 1997;82: 2433-2438.
60. Dorn LD, Burgess ES, Dichek HL, Putnam FW, Chrousos GP, Gold PW: Thyroid hormone concentrations in depressed and nondepressed adolescents: Group differences and behavioral relations. J Am Acad Child Adolesc Psychiatry 1996;35:299-306.
61. Whybrow PC: The therapeutic use of triidothyronine and high dose thyroxine in psychiatric disorder. Acta Med Austriaca 1994;21(2):47-52.
62. Sokolov ST, Kutcher SP, Joffe RT: Basal thyroid indices in adolescent depression and bipolar disorder. J Am Acad Child Adolesc Psychiatry 1994;33:469-475.
63. Zeitlhofer J, Saletu B, Stary J, Ahmadi R: Cerebral function in hyperthyroid patients. Psychopathology, psychometric variables, central arousal and time perception before and after thyreostatic therapy. Neuropsychobiology 1984; 11:89-93.
64. Peet M, Peters S: Drug-induced mania. Drug Safety 1995;12:146-153.
65. Bengtsson B-Å, Edén S, Lönn LJ, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tölli J, Sjöström L, Isaksson OGP: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309-317.
66. Mårdh G, Lundin K, Borg G, Jonsson B, Lindeberg A on behalf of the investigators: Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: Combined data from 12 European placebo-controlled clinical trials. Endocrinol Metab 1994;1(suppl A):43-49.
67. Beshyah SA, Freemantie C, Shahi M, Anyaoku V, Merson S, Lynch S, Skinner E, Sharp P, Foale R, Johnston DG: Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin Endocrinol 1995;42:73-84.
68. Kind P, Gudex M: Measuring health status in the community: A comparison of methods. J Epidemiol Community Health 1994;48:86-91.
69. Bardsley MJ, Astell S, McCallum A, Home PD: The performance of three measures of health status in an outpatient diabetes population. Diabetic Med 1993;10:619-626.
70. De Boer H, Blok GJ, Voerman B, Phillips M, Schouten J: Serum lipid levels in growth hormone deficient men. Metabolism 1994;43:199-203.
71. Carrol PV, Littlewood R, Weissberger AJ, Bogalho P, McGauley G, Sönksen PH, Russel-Jones DL: The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults. Eur J Endocrinol 1997;137:146-153.
72. Holmes SJ, McKenna SP, Doward LC, Hunt SM, Shalet SM: Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency. Endocrinol Metab 1995;2:63-69.
73. Wallymahmed ME, Baker GA, Humphris G, Dewey M, MacFarlane IA: The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency. Clin Endocrinol 1996;44:403-411.
74. Almqvist O, Thorén M, Sääf M, Eriksson O: Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: A pilot study. Psychoneuroendocrinology 1986;11:347-352.
75. Sartorio A, Molinari E, Riva G, Conti A, Morabito F, Faglia G: Growth hormone treatment in adults with childhood onset growth hormone deficiency: Effects on psychological capabilities. Horm Res 1995;44:6-11.
76. Deijen JB, de Boer H, van der Veen EA: Cognitive changes during GH replacement in adult men. Psychoneuroendocrinology, in press.
77. Lai Z, Emtner M, Roos P, Nyberg F: Characterization of putative growth hormone receptors in human choroid plexus. Brain Res 1991;546: 222-226.
78. Lobie PE, Garcia Arragon J, Lincoln D, Barnard R, Wilcox JN, Waters MJ: Localization and ontogeny of growth hormone receptor gene expression in central nervous system. Dev Brain Res 1993;74:225-233.
79. Wyss JM, Van Groen T: The limbic system: in Conn PM (ed): Neuro-science in Medicine. Philadelphia, Lippincott, 1995, pp 321-342.
80. Thörnwall M, Chhajlani V, LeGreves P, Nyberg F: Detection of growth hormone receptor mRNA in ovine choroid plexus epithelium cell line. Biochem Biophys Res Commun 1995;217: 349-353.
81. Burman P, Hetta J, Wide L, Månsson J-E, Ekman R, Karlsson FA: Growth hormone treatment affects brain neurotransmittors and thyroxine. Clin Endocrinol 1996;44:319-324.
82. Johansson J-O, Larsson G, Elmgren A, Hynsjö L, Lindahl A, Lundberg P-A, Isaksson O, Lindstedt S, Bengtsson B-Å: Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmittors. Neuroendocrinology 1995;61:57-66.
83. Vaerøy H, Nyberg F: Endogenous opoid peptides, substance P, calcitonin gene-related peptide and their relation to fibromyalgia: in Vaerøy H, Merskey H (eds): Progress in Fibromyalgia and Myofascial Pain. Amsterdam, Elsevier, 1993. pp 75-91.
84. Sundberg DK: Chemical messenger systems: in Conn PM (ed): Neuroscience in Medicine. Philadelphia, Lippincott, 1995, pp 403-426.
85. Risby ED, Hsiao JK, Sunderland T, Ågren H, Rudorfer MV, Potter WZ: The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio. Clin Pharmacol Ther 1987;42:547-554.
86. Hyman SE, Nestler EJ: The Molecular Foundations of Psychiatry. Washington, American Psychiatric Press, 1993, pp 56-135.
87. Gardner D: Synaptic transmission; in Conn PM (ed): Neuroscience in Medicine. Philadelphia, Lippincott, 1995, pp 75-114.
88. Svensson A, Pileblad E, Carlsson M: A comparison between the noncompetitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CCPene with regard to dopamine turnover and locomotor stimulatory properties in mice. J Neural Transm Gen Sect 1991;85:117-129.
89. Laurberg P, Jakobsen PE, Hoeck HC, Vestergaard P: Growth hormone thyroid function: Is secondary thyroid failure underdiagnosed in growth hormone deficient patients? Thyroidology 1994;6:73-79.
90. Whybrow PC: Behavioral and psychiatric aspects of hypothyroidism; in Braverman LE, Utiger RD (eds): Werner and Ingbar's the Thyroid. A Fundamental and Clinical Text. Philadelphia, Lippincott, 1991, pp 1078-1083.
91. Wilson IC, Prange AJ, McClane TK, Rabon AM, Lipton MA: Thyroid-hormone enhancement of imipramine in nonretarded depressions. N Engl J Med 1970;282:1063-1067.
92. Goodwin FK, Prange AJ, Post RM, Muscettola G, Lipton MA: Potentiation of antidepressant effects by triiodotyronine in tricyclic nonresponders. Am J Psychiatry 1982;139:34-38.
93. Thompson P, Burman KD, Wright FD, Potter MW, Wartofsky L: Iodothyronine levels in human cerebrospinal fluid. J Clin Endocrinol Metab 1982;54:653-655.
94. Kierkegaard C, Faber J: Free thyroxine and 3,3′,5′-triidothyronine levels in cerebrospinal fluid in patients with endogenous depression. Acta Endocrinol (Copenh) 1991;124:166-172.